Suggestions
Louis Roy
CEO/Founder of OPTEL : Leading supply chain transformation for a better world
Louis Roy is an engineer and physicist who is the founder and owner of OPTEL Group, a B Corp dedicated to using disruptive technologies to create a better world and promote corporate responsibility. He actively participates in organizations like the World Business Council for Sustainable Development (WBCSD), United Nations Global Compact (UN GC), and SCALE.AI to drive supply chain transformation and transparency. With operations in Canada, USA, Brazil, Ireland, India, and Germany, OPTEL has digitized the product life cycle, enabling efficient tracking of material flow and environmental/social factors. Through 4,000 IT data connectors and tracking 50 billion products annually, they provide crucial visibility across the supply chain, connecting consumers, farms, mines, and brands.
Highlights
Real use case on leveraging traceability for sustainability and supply chain performance. Traceability is a key enabler for circular economy. OPTEL's solutions are already used in recycle content for plastics, metals, and soon in the EV battery value chain. #traceability #CircularEconomy #sustainability
Transforming Pharma Compliance into ESG-GHG Traceability Excellence
In the pharmaceutical industry, the rigorous standards of the FDA-DSCSA and EU Falsified Medicine Directive have not just ensured product integrity; they've laid the groundwork for our next leap: ESG-GHG traceability. These stringent compliance frameworks are more than regulatory achievements; they are the blueprints for embedding sustainability into our operations.
Our journey from compliance to environmental stewardship is both a strategic imperative and a testament to our commitment to global health. Leveraging the robust infrastructure and sophisticated technologies developed for DSCSA and EU compliance, we're poised to accelerate ESG-GHG traceability, enhancing operational efficiency and corporate responsibility.
As industry leaders, it's our moment to pivot from ensuring medicine integrity to championing planetary health. This synergy between regulatory adherence and environmental traceability isn't just an alignment; it's a transformative stride towards a sustainable, traceable, and responsible pharma industry.
#PharmaSustainability #ESG #GHG #Traceability #FDADSCSA #FalsifiedMedicineDirective #SustainablePharma
